Related Experiment Video
Updated: Aug 11, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
1The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Daxx was first identified as a protein that binds the cytosolic domain of Fas and links this receptor to an apoptosis pathway involving activation of Jun N-terminal kinase (JNK). We show here that cells overexpressing the human homolog of Daxx (hDaxx) display enhanced sensitivity to apoptosis induced by Fas but not by several other cell death stimuli. hDaxx-mediated enhancement of Fas-induced apoptosis was correlated with accelerated activation of caspases but not with JNK induction. Although specifically enhancing Fas function, hDaxx does not bind Fas and instead is found in the nucleus where it localizes to PML oncogenic domains (PODs). Moreover, the hDaxx protein also exhibits the ability to repress transcription. Mutagenesis studies demonstrated a correlation between the localization of hDaxx to PODs and its ability to enhance Fas-induced cell death. Arsenic trioxide (As(2)O(3)), an agent that accentuates POD formation, collaborated synergistically with overexpression of hDaxx to increase cellular sensitivity to Fas-induced apoptosis. Taken together, these findings argue that hDaxx promotes sensitivity to Fas from a nuclear location, probably by modulating the transcription of genes involved in Fas-induced caspase activation and apoptosis.
Insights
Human Daxx (hDaxx) enhances sensitivity to Fas-induced apoptosis by affecting caspase activation. This nuclear protein localizes to PML oncogenic domains (PODs) and represses transcription, influencing cell death pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Daxx protein initially identified for binding Fas receptor and linking to Jun N-terminal kinase (JNK) mediated apoptosis.
- Fas receptor is a key mediator of programmed cell death.
Purpose of the Study:
- To investigate the role of human Daxx (hDaxx) in Fas-mediated apoptosis.
- To elucidate the mechanism by which hDaxx influences cellular sensitivity to apoptosis.
Main Methods:
- Overexpression of hDaxx in cells.
- Assays for apoptosis induction by various stimuli.
- Analysis of caspase activation and JNK induction.
- Subcellular localization studies of hDaxx.
- Transcriptional repression assays.
- Mutagenesis studies.
- Synergistic treatment with arsenic trioxide (As(2)O(3)).
Main Results:
- Overexpression of hDaxx specifically enhanced sensitivity to Fas-induced apoptosis, but not other death stimuli.
- hDaxx overexpression accelerated caspase activation without affecting JNK induction.
- hDaxx localizes to the nucleus within PML oncogenic domains (PODs) and exhibits transcriptional repression activity.
- Localization to PODs correlated with enhanced Fas-induced cell death.
- Arsenic trioxide synergized with hDaxx to further increase sensitivity to Fas-induced apoptosis.
Conclusions:
- hDaxx enhances Fas-induced apoptosis through a nuclear mechanism, independent of direct Fas binding.
- hDaxx's ability to repress transcription and localize to PODs is crucial for its role in sensitizing cells to Fas-mediated death.
- These findings suggest hDaxx modulates the transcription of genes involved in Fas-induced caspase activation and apoptosis.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

